期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

冠脉介入治疗对肌钙蛋白Ⅰ和超敏C反应蛋白的影响 被引量：2

下载PDF
导出
摘要 目的评价冠脉介入治疗(PCI)对患者血中肌钙蛋白Ⅰ(cTnⅠ)及超敏C反应蛋白(hsCRP)的影响。方法选择在我院行冠脉介入治疗的患者为研究对象,一组同期行冠脉造影的患者为对照组。分别于手术当天及术后24h采集静脉血测定血浆cTnⅠ及hsCRP浓度。结果冠脉介入治疗术前及术后血浆cTnⅠ及hsCRP显著高于同期对照组(P<0.01);研究组术后cTnⅠ及hsCRP浓度差异无显著性(P>0.05)。结论冠脉介入治疗使血液中cTnⅠ及hsCRP水平升高。
作者 杨洪庆
机构地区 天津市静海县医院内一科
出处 《河北医药》 CAS 2007年第2期137-137,共1页 Hebei Medical Journal
关键词 冠脉介入治疗 肌钙蛋白I 超敏C反应蛋白
分类号 R654.2 [医药卫生—外科学]
  • 相关文献

参考文献8

  • 1袁义强 刘怀霖 马业新 等.急性介入治疗高危不稳型心绞痛的临床研究[J].中国全科医学,2005,8:415-415.
  • 2陈君.血清肌钙蛋白T测定对不稳定性心绞痛的预后判定[J].河北医药,2001,23(10):731-732. 被引量：1
  • 3Harrington RA.Cardiac enzyme elevations after percutaneous coronary intervention:Myonecrosis,the coronary microcirculation and mortality.J Am Coll Cardiol,2000,35:1142-1144.
  • 4Saadeddin SM,Habbab MA,Sobki SH,et al.Minor myocardial injuryj after elective uncomplicated successful PTCA with or without stenting:detection by cardiac troponins.Catheter Cardiovasc Interv,2001,53:188-192.
  • 5Hamm CW,Goldmann BV,Heeschen C,et al.Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I.N Engl J Med,1997,337:1648-1653.
  • 6Maseri A.Inflammation,atherosclerosis,and ischemic events exploring the hidden side of the moon.N Engl J Med,1997,336:1014-1016.
  • 7Ross R.Atheroselerosis is an inflammatory disease.Am Heart J,1999,138:s419-420.
  • 8Blankenberg S,Rupprecht HJ,Bickel C,et al,The rote of inflammation and infection in acute coronary syndrome.Herz,2001,26(Suppl1):9-18.

二级参考文献1

同被引文献13

  • 1袁国跃,周丽斌,唐金凤,杨颖,顾卫琼,李凤英,洪洁,顾燕云,徐敏,杜鹏飞,李小英,宁光,陈名道.糖耐量受损和2型糖尿病患者血清C反应蛋白与胰岛素敏感指数、脂联素的关系[J].中华内分泌代谢杂志,2005,21(6):507-510. 被引量：50
  • 2Mark RA, Akihiro N, Anthony K, et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation, 1995,92:2127-2134.
  • 3Rifai N, Joubran R, Yu H, et al. Inflammatory markers in men with angiographically documented coronary heart disease clinical chemistry, 1999, 45 : 1967-1973.
  • 4Jager A, van Hinsbergh VW, Kostense PJ, et al. yon Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn study. Arterioscler Thromb Vasc Bial, 1999, 19: 3071-3078.
  • 5Minna S, Jukka M, Markku L, et al. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes. Diabetes Care, 2006,29:329-333.
  • 6Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol,2000,20 : 1595-1599.
  • 7Noriyuki O,Shinji K,Tohru F, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation, 2003,107:671-674.
  • 8Piana RN, Paik GY, Moscucci S, et al. Incidence and treatment of no-reflow after percutaneous coronary intervention. Circulation, 1994,89: 2514-2518.
  • 9Biasucci LM. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application of clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular disease: a background paper. Circulatian, 2004, 110: e560-e567.
  • 10Ridker P, Cannon C, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 2005,352:20-28.

引证文献2

二级引证文献6

河北医药
2007年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部